Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Karyopharm Therapeutics (KPTI) Q2 2026 Earnings
KPTI
14
May
Confirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-5.71
-4.22
-2.73
-1.24
Details
Expected EPS
-1.417143
Actual EPS
-1.24
Surprise EPS
0.18
Surprise Percent
+12.5%
Description
Karyopharm Therapeutics (KPTI) has reported earnings of -1.24 per share for Q2 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login